Consolidated organic revenue growth of approximately 17% year-on-year reflected strength at our Electronics and Scientific segment.
Electronics revenue increased approximately 37% year-on-year, primarily due to a broad-based geographical recovery with continued solid demand for relays in renewable energy and electric vehicle applications along with positive trends in transportation, appliance, test and measurement and distribution end-markets.
Scientific segment revenue increased approximately 29% year-on-year driven by retail pharmacies, clinical laboratory, and academic institution end-markets.
Consolidated adjusted operating margin of 13.4% was a 250 basis point year-on-year increase and represented our second consecutive quarter of delivering our highest consolidated margin in Standex's history.
Sequentially, total company backlog realizable in under one year increased approximately 12%, with strength, particularly at the Electronics, Specialty Solutions and Engraving segments.
Revenue increased approximately $20.6 million or 37.2% year-on-year, including 36.1% organic growth reflecting continued broad-based geographic and end-market strength, as well as a 1.1% positive contribution from foreign exchange.
Operating income increased approximately $9.1 million or 100% year-on-year due to operating leverage associated with revenue growth and productivity initiatives, partially offset by increased raw material and freight costs.
Looking ahead, we have a very active new business opportunity funnel for approximately $61 million, which is expected to deliver first year sales of $19 million with positive trends across all major geographic areas and business units, and are well positioned to further capture additional customer business.
Electronics backlog realizable under a year sequentially increased approximately $13 million or 11% in fiscal first quarter 2002.
Year-on-year revenue decreased approximately $1.2 million or 3.4% and operating income was nearly $1 million lower or 17% decrease due to the timing of projects and geographic mix, partially offset by productivity actions.
Laneway sales of approximately $14.9 million represented a 27% increase year-on-year, including a positive demand outlook for soft trim tools, laser engraving and tool finishing.
Sequentially, backlog realizable under a year increased $5.9 million or approximately 44% in fiscal first quarter 2002.
Revenue increased approximately $4.9 million or 29.2% year-on-year reflecting positive trends at pharmaceutical channels, clinical laboratories and academic institutions.
Operating income increased approximately $0.4 million or 10.6% year-on-year due to volume growth and pricing initiatives, balanced with investments to support future growth opportunities and higher freight costs.
Sequentially, backlog realizable under a year increased $1.6 million or approximately 27% in fiscal first quarter in fiscal 2022.
First quarter revenue at $17.6 million was similar year-on-year due to positive trends in the space end-market balanced with the absence of the recently divested Enginetics and the economic impact of COVID-19 on this segments end-markets.
Operating income increased approximately $0.4 million, representing a 91.7% increase year-on-year, reflecting product mix and ongoing productivity initiatives offset by a $1.1 million one-time project-related charge.
On a year-on-year basis, Specialty Solutions revenue increased approximately $0.2 million, or slightly under 1%, and operating income decreased $1.1 million or 27.9%.
We have a very strong backlog position realizable under a year, which sequentially increased $8.7 million or approximately 33% in the first quarter.
Organic revenue growth of approximately 17% year-on-year reflected solid demand trends at Electronics and Scientific segments.
From a margin standpoint, adjusted consolidating operating margin of 13.4% increased both, sequentially and year-on-year, and represented our second consecutive quarter of highest margin in Standex's history.
On a consolidated basis total revenue increased 16.1% year-on-year from $151.3 million in fiscal first quarter 2021 to $175.6 million this quarter.
Enginetics contributed approximately $3 million in revenue in the fiscal first quarter of 2021.
On a year-on-year basis, our adjusted operating margin increased 250 basis points to 13.4%, reflecting operating leverage associated with revenue growth and the readout of price and productivity actions.
This was partially offset by a $1.1 million one-time project related charge at Engineering Technologies segment, and the financial impact of work stoppage in the Specialty Solutions segment which has since been resolved.
As expected, our tax rate increased to 25% compared to 22% in the first quarter of 2021.
We expect that second quarter tax rate will be similar to the first quarter rate, and that the overall tax rate for fiscal 2022 to be in the 24% range.
Adjusted earnings per share was $1.34 in the first quarter of 2022 compared to $0.96 a year ago.
We generated free cash flow of approximately $8.1 million in the first quarter of 2022 compared to free cash flow of $4.4 million in the first quarter of 2021.
We continue to successfully execute on our financial initiative with working capital turns of 5.6 times, representing a 33% increase year-on-year.
Standex had net debt of $68.9 million at the end of September compared to $63.1 million at the end of June, reflecting free cash flow of approximately $8.1 million offset by $9.5 million of stock repurchases along with dividends and changes in foreign exchange.
Our net debt for fiscal first quarter of 2022 consisted primarily of long-term debt of $199.6 million.
Cash and cash equivalents totaled $130.7 million, with approximately $102 million held by foreign subs.
We had approximately $267 million of available liquidity at the end of September.
Our net debt to adjusted EBITDA leverage ratio was approximately 0.58 times, with a net debt to total capital ratio of 11.8%.
We expect that we will repatriate approximately $35 million in cash in fiscal 2022.
From a capital allocation perspective, we repurchased approximately 97,000 shares for $9.5 million in fiscal first quarter 2022, with approximately $12.5 million remaining on our current repurchase authorization.
We also declared our 229th consecutive quarterly cash dividend on October 28th of $0.96 per share, approximately 8% increase over the prior four quarterly dividend payments.
Finally, we expect capital expenditures of approximately $25 million to $30 million in fiscal 2022.
